What is another word for Late Onset Globoid Cell Leukodystrophy?
Pronunciation: [lˈe͡ɪt ˈɒnsɛt ɡlˈɒbɔ͡ɪd sˈɛl lˈuːkədˌɪstɹəfi] (IPA) 
Late Onset Globoid Cell Leukodystrophy, also known as Krabbe disease, is a rare and debilitating genetic disorder that affects the nervous system. Synonymous terms for this condition include Adult Krabbe Disease, Late Infantile Krabbe Disease, and Late-Onset Galactosylceramidase Deficiency. Despite minor variations, these terms all refer to the same progressive and degenerative neurological disorder characterized by a deficiency of the enzyme galactosylceramidase. This deficiency results in the accumulation of harmful substances in the brain and spinal cord, leading to a range of symptoms including muscle weakness, loss of coordination, vision and hearing problems, and cognitive decline. While treatments for Late Onset Globoid Cell Leukodystrophy are limited, ongoing research offers hope for future therapeutic interventions to improve the quality of life for affected individuals.
